Slideshow

What Impact of Weight on GLP-1-stimulated Insulin Secretion?

Author(s):

The size of the incretin effect among healthy subjects may vary up to 2-fold, suggesting differences in ß-cell sensitivity to GLP-1. Does BMI play a role in this variability?

The body's insulin response to oral glucose can be reduced by 30% to 40% by blocking the action of endogenous glucagon-like polypeptide-1 (GLP-1) but the effect on insulin secretion is widely variable. The magnitude of the incretin effect has also been shown to vary 1.5-2-fold among healthy subjects. Both observations suggest interindividual differences in ß-cell sensitivity to GLP-1. The slides above summarize a recent study that was based on the hypothesis that insulin secretion would be less sensitive to stimulation by GLP-1 in obese vs lean subjects who were healthy.The authors were surprised by the results. Find out why.

Related Videos
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
© 2025 MJH Life Sciences

All rights reserved.